Enteral Feeding Formulas Market

Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and Others formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the market is segmented into adults and pediatrics. On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and Others applications. Others applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the enteral feeding formulas market in 2015, primarily due to the high prevalence of malnutrition among cancer patients. By end user, the market is segmented into hospitals and long-term care facilities. Long-term care facilities are further divided into homecare agencies & hospices, nursing homes, and assisted living facilities.
Enteral Feeding Formulas Market contains market size and forecasts of Enteral Feeding Formulas in Global, including the following market information:
Global Enteral Feeding Formulas Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Enteral Feeding Formulas market was valued at 4581.3 million in 2021 and is projected to reach US$ 6079.2 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adults Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Enteral Feeding Formulas include Abbott Laboratories, Nestle, Danone, Fresenius Kabi, Mead Johnson Nutrition Company, B.Braun Melsungen, Hormel Foods Corporation, Meiji Holdings and Victus and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Enteral Feeding Formulas companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enteral Feeding Formulas Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Enteral Feeding Formulas Market Segment Percentages, by Type, 2021 (%)
Adults
Pediatrics
Global Enteral Feeding Formulas Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Enteral Feeding Formulas Market Segment Percentages, by Application, 2021 (%)
Oncology
Gastroenterology
Neurology
Diabetes
Critical Care
Others Applications
Global Enteral Feeding Formulas Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Enteral Feeding Formulas Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enteral Feeding Formulas revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Enteral Feeding Formulas revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Nestle
Danone
Fresenius Kabi
Mead Johnson Nutrition Company
B.Braun Melsungen
Hormel Foods Corporation
Meiji Holdings
Victus
Global Health Products